Lopes, Carla Duque 
; Possato, Bruna ; Gaspari, Ana Paula Segantin ; Oliveira, Ronaldo Junio ; Abram, Ulrich ; Almeida, José P. A; Rocho, Fernanda dos Reis ; Leitão, Andrei ; Montanari, Carlos Alberto ; Maia, Pedro Ivo da Silva ; Silva, João Santana da ; Albuquerque, Sérgio de ; Carneiro, Zumira Aparecida
Source: ACS Infectious Diseases. Unidades: IQSC, FMRP, FCFRP
Subjects: BIOQUÍMICA, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Carla Duque et al. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease. ACS Infectious Diseases, v. 5, n. 10, p. 1698-1707, 2019Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.8b00284. Acesso em: 10 nov. 2024.APA
Lopes, C. D., Possato, B., Gaspari, A. P. S., Oliveira, R. J., Abram, U., Almeida, J. P. A., et al. (2019). Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease. ACS Infectious Diseases, 5( 10), 1698-1707. doi:10.1021/acsinfecdis.8b00284NLM
Lopes CD, Possato B, Gaspari APS, Oliveira RJ, Abram U, Almeida JPA, Rocho F dos R, Leitão A, Montanari CA, Maia PI da S, Silva JS da, Albuquerque S de, Carneiro ZA. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease [Internet]. ACS Infectious Diseases. 2019 ; 5( 10): 1698-1707.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1021/acsinfecdis.8b00284Vancouver
Lopes CD, Possato B, Gaspari APS, Oliveira RJ, Abram U, Almeida JPA, Rocho F dos R, Leitão A, Montanari CA, Maia PI da S, Silva JS da, Albuquerque S de, Carneiro ZA. Organometallic Gold(III) complex [Au(Hdamp)(L14)]+ (L1 = SNSDonating Thiosemicarbazone) as a candidate to new formulations against Chagas disease [Internet]. ACS Infectious Diseases. 2019 ; 5( 10): 1698-1707.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1021/acsinfecdis.8b00284
